Back to Search Start Over

Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion

Authors :
Salinas, Eduardo
Boisvert, Maude
Upadhyay, Amit A.
Bedard, Nathalie
Nelson, Sydney A.
Bruneau, Julie
Derdeyn, Cynthia A.
Marcotrigiano, Joseph
Evans, Matthew J.
Bosinger, Steven E.
Shoukry, Naglaa H.
Grakoui, Arash
Source :
Journal of Clinical Investigation. February, 2021, Vol. 131 Issue 2
Publication Year :
2021

Abstract

Early appearance of neutralizing antibodies during acute hepatitis C virus (HCV) infection is associated with spontaneous viral clearance. However, the longitudinal changes in antigen-specific memory B cell (MBCs) associated with divergent HCV infection outcomes remain undefined. We characterized longitudinal changes in E2 glycoprotein-specific MBCs from subjects who either spontaneously resolved acute HCV infection or progressed to chronic infection, using single-cell RNA-seq and functional assays. HCV-specific antibodies in plasma from chronically infected subjects recognized multiple E2 genotypes, while those from spontaneous resolvers exhibited variable cross-reactivity to heterotypic E2. E2-specific MBCs from spontaneous resolvers peaked early after infection (4-6 months), following expansion of activated circulating T follicular helper cells (cTfh) expressing interleukin 21. In contrast, E2-specific MBCs from chronically infected subjects, enriched in VH1-69, expanded during persistent infection (> 1 year), in the absence of significantly activated cTfh expansion. Early E2- specific MBCs from spontaneous resolvers produced monoclonal antibodies (mAbs) with fewer somatic hypermutations and lower E2 binding but similar neutralization as mAbs from late E2-specific MBCs of chronically infected subjects. These findings indicate that early cTfh activity accelerates expansion of E2-specific MBCs during acute infection, which might contribute to spontaneous clearance of HCV.<br />Introduction Mechanisms of immune protection are not well defined for many rapidly evolving RNA viruses, such as HIV and hepatitis C virus (HCV), which affect millions worldwide without effective vaccines [...]

Details

Language :
English
ISSN :
00219738
Volume :
131
Issue :
2
Database :
Gale General OneFile
Journal :
Journal of Clinical Investigation
Publication Type :
Academic Journal
Accession number :
edsgcl.649350587
Full Text :
https://doi.org/10.1172/JCI140590